116,345 Shares in Sotera Health Company $SHC Purchased by OP Asset Management Ltd

OP Asset Management Ltd bought a new position in shares of Sotera Health Company (NASDAQ:SHC) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 116,345 shares of the company’s stock, valued at approximately $1,668,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. IFP Advisors Inc grew its stake in shares of Sotera Health by 1,105.6% in the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after buying an additional 1,371 shares during the period. Rothschild Investment LLC acquired a new position in Sotera Health in the fourth quarter valued at approximately $27,000. True Wealth Design LLC grew its position in Sotera Health by 389.3% in the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after acquiring an additional 1,456 shares during the period. Eurizon Capital SGR S.p.A. acquired a new stake in Sotera Health during the fourth quarter worth $40,000. Finally, Allworth Financial LP increased its stake in Sotera Health by 922.0% during the fourth quarter. Allworth Financial LP now owns 3,025 shares of the company’s stock worth $53,000 after acquiring an additional 2,729 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on SHC shares. Barclays upped their price target on Sotera Health from $18.00 to $19.00 and gave the company an “overweight” rating in a research note on Wednesday. Wall Street Zen lowered shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Piper Sandler reaffirmed an “overweight” rating and issued a $22.00 target price (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. The Goldman Sachs Group assumed coverage on shares of Sotera Health in a research note on Friday, June 5th. They set a “buy” rating and a $20.00 target price for the company. Finally, UBS Group set a $19.00 price target on shares of Sotera Health in a research note on Wednesday. Eight equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $20.25.

Insider Activity at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of Sotera Health stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 15.36% of the company’s stock.

Sotera Health Price Performance

SHC stock opened at $17.38 on Monday. The business’s fifty day moving average price is $15.79 and its 200 day moving average price is $16.32. Sotera Health Company has a 12-month low of $10.93 and a 12-month high of $19.85. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56. The company has a market capitalization of $4.96 billion, a PE ratio of 42.39 and a beta of 1.79.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The company had revenue of $280.05 million during the quarter, compared to analysts’ expectations of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.Sotera Health’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same period last year, the business posted $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, sell-side analysts anticipate that Sotera Health Company will post 0.88 EPS for the current year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.